Literature DB >> 20442513

Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.

David Chu1, Wendy Kohlmann, Douglas G Adler.   

Abstract

Despite recent diagnostic and therapeutic advances, pancreatic cancer still carries a poor prognosis. Screening high-risk individuals is a relatively new concept with regards to pancreatic cancer but is an area of intense study. Significant effort has been invested in identifying risk factors for pancreatic cancer. Risk factors for pancreatic cancer can be classified into three broad categories: demographic, environmental (host), and hereditary (genetic) predisposition. This manuscript will review the risk factors and genetic syndromes associated with increased risk of developing pancreatic cancer, the role of genetic testing in the evaluation of high-risk patients, the available serologic and imaging tests that can be used to screen these individuals, and will summarize the available literature on attempts at pancreatic cancer screening to date.

Entities:  

Mesh:

Year:  2010        PMID: 20442513

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  28 in total

1.  Significance of microRNA-based biomarkers for pancreatic cancer.

Authors:  Sukhwinder Kaur; Shiv Ram Krishn; Satyanarayana Rachagani; Surinder K Batra
Journal:  Ann Transl Med       Date:  2015-10

2.  Association between single-nucleotide polymorphisms of OGG1 gene and pancreatic cancer risk in Chinese Han population.

Authors:  Hongxu Chen; Bo Zhou; Xiang Lan; Dong Wei; Tao Yuan; Ping Chen
Journal:  Tumour Biol       Date:  2013-09-03

Review 3.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  Current status and progress of pancreatic cancer in China.

Authors:  Quan-Jun Lin; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 5.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

6.  Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

Authors:  Wigdan Al-Sukhni; Ayelet Borgida; Heidi Rothenmund; Spring Holter; Kara Semotiuk; Robert Grant; Stephanie Wilson; Malcolm Moore; Steven Narod; Kartik Jhaveri; Masoom A Haider; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2011-11-30       Impact factor: 3.452

7.  Association between OGG1 gene single nucleotide polymorphisms and risk of pancreatic cancer in Chinese.

Authors:  Chengli Liu; Hui Huang; Cheng Wang; Yalin Kong; Hui Zhang; Hongyi Zhang
Journal:  Med Oncol       Date:  2014-06-17       Impact factor: 3.064

Review 8.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

Review 9.  Early diagnosis of pancreatic cancer: challenges and new developments.

Authors:  Sukhwinder Kaur; Michael J Baine; Maneesh Jain; Aaron R Sasson; Surinder K Batra
Journal:  Biomark Med       Date:  2012-10       Impact factor: 2.851

10.  Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.

Authors:  Di Wang; Xiao-Zhong Guo; Hong-Yu Li; Jia-Jun Zhao; Xiao-Dong Shao; Chun-Yan Wu
Journal:  Tumour Biol       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.